Investigational Site Number 1240003

Vancouver V6T 2B5

0 studies enrolling now · 3 studies all time

What they study most

Relapsing Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early